Cargando…

HDMTX-based polychemotherapy including intraventricular therapy in elderly patients with primary CNS lymphoma: a single center series

BACKGROUND: To investigate outcome and toxicity of high-dose systemic methotrexate (HDMTX)-based polychemotherapy and intracerebroventricular (ICV) chemotherapy via an Ommaya reservoir in elderly patients with primary central nervous system lymphoma (PCNSL). METHODS: We performed a retrospective ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seidel, Sabine, Kowalski, Thomas, Margold, Michelle, Baraniskin, Alexander, Schroers, Roland, Martus, Peter, Schlegel, Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549157/ https://www.ncbi.nlm.nih.gov/pubmed/33101460 http://dx.doi.org/10.1177/1756286420951087

Ejemplares similares

HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a monocentric retrospective analysis
por: Seidel, Sabine, et al.
Publicado: (2019)

Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome
por: Seidel, Sabine, et al.
Publicado: (2021)

The value of bone marrow biopsy for staging of patients with primary CNS lymphoma
por: Margold, Michelle, et al.
Publicado: (2021)

Survival, prognostic factors, hospitalization time and clinical performance status after first cerebral relapse or progression in 54 patients with primary CNS lymphoma not eligible for high dose chemotherapy: a retrospective analysis
por: Seidel, Sabine, et al.
Publicado: (2023)

High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity
por: Seidel, Sabine, et al.
Publicado: (2022)

Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy
por: Kebir, Sied, et al.
Publicado: (2012)

NOXA as critical mediator for drug combinations in polychemotherapy
por: Ehrhardt, H, et al.
Publicado: (2012)

Acute pancreatitis associated with multibacillary polychemotherapy for leprosy
por: Maciel, Lucas Guimarães, et al.
Publicado: (2021)

Liquid Biopsy and Other Non-Invasive Diagnostic Measures in PCNSL
por: Baraniskin, Alexander, et al.
Publicado: (2021)

PB2106: REDUCTION OF METHOTREXATE (MTX) LEVELS AFTER GLUCARPIDASE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AT RISK OF CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT WHO RECEIVE HDMTX: PHASE 2
por: De La Fuente, A., et al.
Publicado: (2022)

Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications
por: Boggio, Elena, et al.
Publicado: (2023)

Primary CNS vasculitis presenting as intraventricular bleeding
por: Pillai, Sreeja Hareendranathan, et al.
Publicado: (2016)

The Toxic Effects of Polychemotherapy onto the Liver Are Accelerated by the Upregulated MDR of Lymphosarcoma
por: Sen'kova, Alexandra V., et al.
Publicado: (2012)

Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients
por: Mosleh, Ema, et al.
Publicado: (2023)

Quantification of cell-free DNAfor the analysis of CD19-CAR-T cells during lymphoma treatment
por: Mika, Thomas, et al.
Publicado: (2021)

Desmoid Tumor Treated with Polychemotherapy Followed by Imatinib: A Case Report and Review of the Literature
por: Knechtel, Gudrun, et al.
Publicado: (2010)

Adverse effects of polychemotherapy for leprosy in 13 years of follow-up at a university hospital()()
por: Tortelly, Violeta Duarte, et al.
Publicado: (2021)

BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR‐T cell cytotoxicity
por: Poussard, Margaux, et al.
Publicado: (2020)

Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma
por: Seidel, Sabine, et al.
Publicado: (2020)

A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer.
por: Pronzato, P., et al.
Publicado: (1996)

Multidrug Resistance Phenotype in the RMS‐GR Human Rhabdomyosarcoma Cell Line Obtained after Polychemotherapy
por: Prados, Jose, et al.
Publicado: (1999)

Achievement of complete in vitro spermatogenesis in testicular tissues from prepubertal mice exposed to mono- or polychemotherapy
por: Delessard, Marion, et al.
Publicado: (2022)

Is There an Indication for First Line Radiotherapy in Primary CNS Lymphoma?
por: Seidel, Clemens, et al.
Publicado: (2021)

Successful Chimeric Antigen Receptor (CAR) T-Cell Treatment in Aggressive Lymphoma Despite Coronavirus Disease 2019 (CoVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication - Case Report
por: Nilius-Eliliwi, Verena, et al.
Publicado: (2021)

A Successful Treatment of Relapsed Primary CNS Lymphoma Patient with Intraventricular Rituximab Followed by High-Dose Chemotherapy with Autologous Stem Cell Rescue
por: Hong, Sung Jin, et al.
Publicado: (2009)

Excellent Biochemical Response to Polychemotherapy with Nab-Paclitaxel/Gemcitabine in an 82-Year-Old Female with Metastatic Breast Cancer
por: Völkl, Siegfried J.
Publicado: (2014)

Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy
por: Maisonobe, Jacques-Antoine, et al.
Publicado: (2012)

Liquid biopsy can cure early colorectal cancer recurrence – Case Report
por: Baraniskin, Alexander, et al.
Publicado: (2023)

Clinical Features, Diagnosis, and Treatment of Primary Intraventricular Lymphoma: Insights From a Monocentric Case Series
por: Cheng, Lidong, et al.
Publicado: (2022)

The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series
por: Bowden, Stephen G, et al.
Publicado: (2020)

Pelger‐Huët anomaly and T‐cell lymphoma
por: Schroers, Roland, et al.
Publicado: (2021)

Primary CNS Lymphoma
por: Phillips, Elizabeth H., et al.
Publicado: (2014)

Pediatric intraventricular meningioma: A series of six cases
por: Dash, Chinmaya, et al.
Publicado: (2016)

Significance of Liquid Biopsy for Monitoring and Therapy Decision of Colorectal Cancer
por: Klein-Scory, Susanne, et al.
Publicado: (2018)

Computertomography-Based Prediction of Complete Response Following Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
por: Maslova, Marina, et al.
Publicado: (2021)

Intrathecal/Intraventricular Colistin for Antibiotic-Resistant Bacterial CNS Infections in Pediatric Population: A Systematic Review
por: Alnaami, Ibrahim, et al.
Publicado: (2022)

Intraventricular CNS aspergillosis in a patient with prior history of COVID-19: Case report and review of literature
por: Kankam, Samuel Berchi, et al.
Publicado: (2022)

SUN-431 Primary CNS Lymphoma Involving the Hypothalamus and Pituitary Gland in an Immunocompetent Host Causing Panhypopituitarism
por: Rios, Marvin, et al.
Publicado: (2019)

Proteomic changes in cerebrospinal fluid from primary central nervous system lymphoma patients are associated with protein ectodomain shedding
por: Waldera-Lupa, Daniel Michael, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6lo83t1mq8dcfscbou4m5u3frb